Search Results 71-80 of 14473 for remdesivir

  1. Get the facts about COVID-19 vaccines - Mayo Clinic

    Find out about the COVID-19 vaccines, the benefits of COVID-19 vaccination and the possible side effects.

  2. A Study to Evaluate Fisetin to Alleviate Dysfunction and Inflammation in COVID-19 Subjects - Mayo Clinic

    hydroxychloroquine, azithromycin, remdesivir, anti-spike antibodies, and/or convalescent plasma are not excluded from the study. Participating Mayo Clinic ...

  3. Temsirolimus (intravenous route) - Mayo Clinic

    Brand Name. US Brand Name · Description. Temsirolimus injection is used to treat advanced kidney cancer. · Before Using. In deciding to use a medicine, the risks ...

  4. Remimazolam (intravenous route) - Mayo Clinic

    Remimazolam injection is used to start and maintain relaxation or sleep in patients undergoing medical procedures lasting 30 minutes or less. This medicine is ...

  5. Mayo experts encouraged by authorization of first pill to treat COVID-19

    Paxlovid, which is made by Pfizer, is the first oral antiviral medication authorized to help people who are infected with COVID-19 before they are hospitalized.

  6. Avibactam/aztreonam (intravenous route) - Mayo Clinic

    Aztreonam and avibactam combination injection is used together with other medicines (eg, metronidazole) to treat complicated infections in the abdomen. This ...

  7. COVID and Diabetes Assessment - Mayo Clinic

    ... remdesivir, molnupiravir, or a monoclonal antibody used for treatment) in 365 days prior to diagnosis (ideally within 180 days) of diabetes diagnosis OR ...

  8. Asthma Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...

  9. Reslizumab (intravenous route) - Mayo Clinic

    Reslizumab injection is used with other medicines for the maintenance treatment of severe asthma in patients with an eosinophilic phenotype. This medicine may ...

  10. A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People with Weakened Immune Systems or at Increased Risk for Poor Outcomes who are Hospitalized Due To Severe COVID-19 - Mayo Clinic

    The purpose of this study is to evaluate the effect of nirmatrelvir/ritonavir compared to placebo/ritonavir on SARS-CoV-2 viral RNA levels in NP swabs in ...